Mouse N-acetyltransferase type 2, the homologue of human N-acetyltransferase type 1
- PMID: 18280460
- PMCID: PMC2279149
- DOI: 10.1016/j.bcp.2007.12.012
Mouse N-acetyltransferase type 2, the homologue of human N-acetyltransferase type 1
Abstract
There is increasing evidence that human arylamine N-acetyltransferase type 1 (NAT1, EC 2.3.1.5), although first identified as a homologue of a drug-metabolising enzyme, appears to be a marker in human oestrogen receptor positive breast cancer. Mouse Nat2 is the mouse equivalent of human NAT1. The development of mouse models of breast cancer is important, and it is essential to explore the biological role of mouse Nat2. We have therefore produced mouse Nat2 as a recombinant protein and have investigated its substrate specificity profile in comparison with human NAT1. In addition, we have tested the effects of inhibitors on mouse Nat2, including compounds which are endogenous and exogenous steroids. We show that tamoxifen, genistein and diethylstilbestrol inhibit mouse Nat2. The steroid analogue, bisphenol A, also inhibits mouse Nat2 enzymic activity and is shown by NMR spectroscopy, through shifts in proton peaks, to bind close to the active site. A three-dimensional structure for human NAT1 has recently been released, and we have used this crystal structure to generate a model of the mouse Nat2 structure. We propose that a conformational change in the structure is required in order for ligands to bind to the active site of the protein.
Figures









Similar articles
-
Differences between murine arylamine N-acetyltransferase type 1 and human arylamine N-acetyltransferase type 2 defined by substrate specificity and inhibitor binding.BMC Pharmacol Toxicol. 2014 Nov 29;15:68. doi: 10.1186/2050-6511-15-68. BMC Pharmacol Toxicol. 2014. PMID: 25432241 Free PMC article.
-
Arylamine N-acetyltransferases: characterization of the substrate specificities and molecular interactions of environmental arylamines with human NAT1 and NAT2.Chem Res Toxicol. 2007 Sep;20(9):1300-8. doi: 10.1021/tx7001614. Epub 2007 Aug 3. Chem Res Toxicol. 2007. PMID: 17672512
-
Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.Mol Pharmacol. 1991 Feb;39(2):184-91. Mol Pharmacol. 1991. PMID: 1996083
-
Arylamine N-acetyltransferases: structural and functional implications of polymorphisms.Toxicology. 2008 Dec 30;254(3):170-83. doi: 10.1016/j.tox.2008.08.022. Epub 2008 Sep 12. Toxicology. 2008. PMID: 18852012 Review.
-
Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2.Curr Drug Metab. 2008 Jul;9(6):471-86. doi: 10.2174/138920008784892065. Curr Drug Metab. 2008. PMID: 18680467 Free PMC article. Review.
Cited by
-
N-acetyltransferase 2 activity and folate levels.Life Sci. 2010 Jan 16;86(3-4):103-6. doi: 10.1016/j.lfs.2009.11.008. Epub 2009 Nov 20. Life Sci. 2010. PMID: 19932120 Free PMC article.
-
Prospective virtual screening with Ultrafast Shape Recognition: the identification of novel inhibitors of arylamine N-acetyltransferases.J R Soc Interface. 2010 Feb 6;7(43):335-42. doi: 10.1098/rsif.2009.0170. Epub 2009 Jul 8. J R Soc Interface. 2010. PMID: 19586957 Free PMC article.
-
Subcellular Protein Labeling by a Spatially Restricted Arylamine N-Acetyltransferase.ACS Chem Biol. 2018 Aug 17;13(8):1932-1937. doi: 10.1021/acschembio.8b00178. Epub 2018 Jun 14. ACS Chem Biol. 2018. PMID: 29851463 Free PMC article.
-
Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.Arch Toxicol. 2018 Aug;92(8):2411-2456. doi: 10.1007/s00204-018-2232-x. Epub 2018 Jun 18. Arch Toxicol. 2018. PMID: 29916051 Free PMC article. Review.
-
A novel color change mechanism for breast cancer biomarker detection: naphthoquinones as specific ligands of human arylamine N-acetyltransferase 1.PLoS One. 2013 Aug 5;8(8):e70600. doi: 10.1371/journal.pone.0070600. Print 2013. PLoS One. 2013. PMID: 23940600 Free PMC article.
References
-
- Sim E., Westwood I., Fullam E. Arylamine N-acetyltransferases. Expert Opin. Drug Metab. Toxicol. 2007;3:169–184. - PubMed
-
- Kawamura A., Graham J., Mushtaq A., Tsiftsoglou S.A., Vath G.M., Hanna P.E. Eukaryotic arylamine N-acetyltransferase Investigation of substrate specificity by high-throughput screening. Biochem. Pharmacol. 2005;69:347–359. - PubMed
-
- Gruvberger S., Ringner M., Chen Y., Panavally S., Saal L.H., Borg A. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res. 2001;61:5979–5984. - PubMed
-
- Hess K.R., Anderson K., Symmans W.F., Valero V., Ibrahim N., Mejia J.A. Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. J. Clin. Oncol. 2006;24:4236–4244. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources